Latest filing published 07 Oct 2019 for Aprea Therapeutics, Inc., €89k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Guido Magni: trading record in brief
Guido Magni has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Adolor Corp and Aprea Therapeutics, Inc. In total, 9 filings cover trades dated from 12 May 2009 to 7 October 2019.
Purchases make up the whole of the open-market record (1 purchase, €89k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 5 option exercises. In 2019 alone, the filings show 1 purchase and no sales.
Most recently, on 7 October 2019, the filings show an open-market purchase worth €89k in Aprea Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Guido Magni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,500 shares@ US$15.00Common StockSEC:0001140361-19-018081:0Canonical exit: 5 Jan 2020 (T+90)
- 135,141 sharesAdolor Common Stock (ADLR)SEC:0001076167-11-000033:5
- 2,958 shares0Common StockSEC:0001076167-10-000007:0
- 2,183 shares0Common StockSEC:0001076167-09-000025:0
4 of 4 declarations
